Home
>
National Drug Code (NDC)
>
Biaxin
Biaxin - 0074-3163-50 - (Clarithromycin)
Drug Information of Biaxin
| Product NDC: | 0074-3163 |
| Proprietary Name: | Biaxin |
| Non Proprietary Name: | Clarithromycin |
| Active Ingredient(s): | 125 mg/5mL & nbsp; Clarithromycin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | GRANULE, FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Biaxin
| Product NDC: | 0074-3163 |
| Labeler Name: | AbbVie Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050698 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19931223 |
Package Information of Biaxin
| Package NDC: | 0074-3163-50 |
| Package Description: | 50 mL in 1 BOTTLE (0074-3163-50) |
NDC Information of Biaxin
| NDC Code | 0074-3163-50 |
| Proprietary Name | Biaxin |
| Package Description | 50 mL in 1 BOTTLE (0074-3163-50) |
| Product NDC | 0074-3163 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clarithromycin |
| Dosage Form Name | GRANULE, FOR SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 19931223 |
| Marketing Category Name | NDA |
| Labeler Name | AbbVie Inc. |
| Substance Name | CLARITHROMYCIN |
| Strength Number | 125 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |
